Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Quinolinone compound, preparation method and pharmaceutical composition of quinolinone compound and application of pharmaceutical composition

A compound, quinolinone technology, applied in the field of medicine, achieves strong anti-Helicobacter pylori effect and overcomes technical defects

Inactive Publication Date: 2013-05-15
CHONGQING UNIV OF TECH
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, it cannot be used to solve the problem of treating digestive system diseases caused by Helicobacter pylori

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Quinolinone compound, preparation method and pharmaceutical composition of quinolinone compound and application of pharmaceutical composition
  • Quinolinone compound, preparation method and pharmaceutical composition of quinolinone compound and application of pharmaceutical composition
  • Quinolinone compound, preparation method and pharmaceutical composition of quinolinone compound and application of pharmaceutical composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Embodiment 1, preparation and synthesis of merlinone compound:

[0044] The preparation of 2-undecyl-3-methyl-4(1H)-quinolinone compound specifically comprises the following steps:

[0045] Step 1: Take 13mmol of o-aminopropiophenone and 20mmol of lauroyl chloride, put them in a 250ml double-necked round bottom flask, add 18mmol of pyridine, 60-80ml of dichloromethane, stir and react at 10-30°C for 4-20 hours, add saturated chlorine Ammonium chloride solution 60-100ml, take the organic phase, concentrate under reduced pressure, conduct silica gel column chromatography on the residue, collect the target object, concentrate under reduced pressure, and dry to obtain lauroamidopropiophenone;

[0046] Step 2: Put 11 mmol of laurylaminopropiophenone in step 1 into a 250 ml double-neck round bottom flask, add 30-40 mmol of sodium tert-butyl alkoxide, 180-240 ml of absolute ethanol, reflux for 12-36 hours, concentrate and recover under reduced pressure Ethanol, add 100-200ml ...

Embodiment 2

[0050] Embodiment 2, the method for preparing merlinone tablet preparation:

[0051] The merolinone prepared in Example 1 is used as raw material to prepare merolinone tablets, and the formula of 1000 tablets is as follows:

[0052] Merlinone (as C 21 h 31 NO meter)

[0053] Mix the raw materials and auxiliary materials, grind them into fine powder, pass through a 100-mesh sieve, take the amount according to the formula, press into tablets, and pack.

Embodiment 3

[0054] Embodiment 3, the method for preparing merlinone capsule:

[0055] Taking the merolinone compound prepared by Preparation Example 1 as raw material, prepare merolinone capsules, the formula of 1000 capsules is as follows:

[0056] Merlinone (as C 21 h 31 NO meter)

Starch and other accessories

100

150

[0057] Mix the raw materials and auxiliary materials, grind them into fine powder, pass through a 100-mesh sieve, take the amount according to the formula, granulate and pack.

[0058] Biological test 1: antibacterial effect of merlinone:

[0059] According to the literature (Ibrahim M, Khan AA, Tiwari SK, et a1. Antimierobia activity of Sapindus mukorossi and Rheum emodi extracts against H. priori: in vitro and in vivo studies. World J Gastroenterol, 2006.14: 7136-7142.) method The effect of merlinone against clinically isolated Helicobacter pylori SW-2 and standard strains was tested (Table 1). Linmycin.

[0060] Table 1 MIC of...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a novel quinolinone compound called after morpholine ketone of which the chemical structure is shown in formula I, the name is 2-undecyl-3-methyl-4(1H)-quinolinone and the chemical formula is C21H31NO. The invention also provides an application of a pharmaceutical composition of the compound in preparation of a medicament for preventing and / or treating a gastritis disease caused by helicobacter pylori. The N at a first site of the quinolinone is not hydroxylated, and the N at a second site of the quinolinone is substituted by undecyl. The quinolinone is completely synthesized. The compound I has a highly-selective inhibiting effect on the helicobacter pylori and can also be used as an efficient proton pump inhibitor, so that the probability of developing a new medicament for treating the gastritis disease caused by the helicobacter pylori is provided.

Description

technical field [0001] The invention provides a quinolinone compound, a preparation method thereof, a pharmaceutical composition containing them and an application, which belong to the technical field of medicine. Background technique [0002] Helicobacter pylori (Helicobacter pylori) is a Gram-negative Helicobacter that colonizes the gastric mucosa. It is an important pathogenic factor that causes chronic gastritis and peptic ulcer. Class I carcinogen in mucosa-associated lymphoid tissue lymphoma and gastric adenocarcinoma. The chronic infection rate of H. pylori in the population of the world is as high as more than 50%, and the rate of infected people in developing countries even reaches 70-90%. The 2001-2004 epidemiological survey of the Digestive Disease Branch of the Chinese Medical Association showed that the infection rate of Helicobacter pylori in my country was 40%-90%, with an average of 59%; the infection rate of children was 25%-59%, with an average of 40%, and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D215/233A61K31/47A61P1/04A61P31/04
Inventor 郑一敏王锐胥秀英张云玲陈海芹
Owner CHONGQING UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products